uk en
LIFE SCIENCES LAWYERS | UKRAINE & CENTRAL ASIA
Menu

LA LAW FIRM (Legal Alliance) founded in 1995, is today one of the leading Ukrainian law firms that provides comprehensive corporate counselling and practical support to national and global companies in Ukraine, СEE & Central Asia.

OUR CLIENTS represent life sciences industries including healthcare and pharmaceuticals, medical devices, cosmetics, biotechnology as well as healthcare institutions.

LEADING ASSOCIATIONS — AIPM Ukraine, APRaD as well as the EBA Healthcare Committee have chosen LA Law Firm as their legal advisor.

4082
According to the results of the recently published international study The Legal 500 Europe, Middle East & Africa 2024 LA Law Firm is recognized among the leading law firms of Ukraine.
2786
LA Law Firm held a webinar "Regulatory changes for pharmaceutical sector in 2024. Conclusions and forecasts". During the event, the participants discussed changes in the Health Technology Assessment procedure, regulation of prices for medicines, the Prozorro Market Electronic Catalogue, regulatory plans to change approaches to the circulation of dietary supplements, etc.
3561
The national ranking features three partners and a counsel across four practice categories. Managing partner Dmytro Aleshko named among the TOP 100 legal practitioners in Ukraine and leaders in Medical Law / Pharmaceuticals.
3544
As soon as the pharmaceutical market began to recover from the adoption of the new List of OTC medicines prohibited for advertising, the Order of the Ministry of Health No. 1894 dated 02.11.2023 suspended its validity until 1 March 2024. In order to understand the legal implications of these developments, it is important to focus on certain aspects.
3256
On October 17, the MOH approved legislation requiring the international non-proprietary name of medicines to be indicated on paper and electronic prescriptions along with the mandatory indication of the form and dosage.
3464
The "Bolar Rule" is a provision that does not recognize as an infringement of a patent for an original medicinal product the actions taken by the applicant of a generic medicinal product (analogue of an original medicinal product) for the purpose of conducting trials and state registration of such medicinal product until the expiry of the patent.
2118
Ukraine has once again declared a battle against counterfeit medicines and is already working on a system for verifying medicines. Some see 2D coding as a panacea, while others see harsh penalties for counterfeiting.​ What does such a system look like in the world, what should Ukraine include in its reform plans to make the fight against counterfeiting real, and what can be done today?​
2760
On 5 September, a webinar was held on "Regulatory changes for pharma in 2023. Prospects for 2024". During the event, the participants discussed the issues of the procurement of medicines​, advertising of medicines and medical devices​, Health​ Technology Assessment, creation of a single regulatory authority in the pharmaceutical sector.​
3030
In the modern world, scientific progress and research never stand still, and scientists regularly make discoveries in the field of chemistry and pharmacy, including those related to cosmetic products. The global community is currently actively discussing the need to make changes to SPF products and cosmetics containing vitamin A.
4172
Leadership lessons for lawyers often focus on how to face up to tough times and take difficult decisions, but few managing partners will have had to square up to the challenges faced by Dmytro Aleshko since February 2022.
If you find out a mistake, please, mark it and select Ctrl+Enter to inform us